Yasmin and Depression suicidal - a phase IV clinical study of FDA data

Summary:

Depression suicidal is reported as a side effect among people who take Yasmin (drospirenone; ethinyl estradiol), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Vitamin B6, and have Cyclothymic disorder.

The phase IV clinical study analyzes which people have Depression suicidal when taking Yasmin. It is created by eHealthMe based on reports of 47,831 people who have side effects when taking Yasmin from the FDA, and is updated regularly.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,855 Yasmin users. Check the latest studies of Yasmin.

What is Depression suicidal?

Depression suicidal (suicide depressive disorder) is found to be associated with 315 drugs and 474 conditions by eHealthMe. Check the latest studies of Depression suicidal.

On Jul, 15, 2026

47,831 people reported to have side effects when taking Yasmin.
Among them, 38 people (0.08%) have Depression suicidal.

Among these 38 people:

How long have people been on Yasmin when they have Depression suicidal? *

What is the gender of people who have Depression suicidal when taking Yasmin? *

female: 100 %
male: 0.0 %

What is the age of people who have Depression suicidal when taking Yasmin? *

What are other drugs people take besides Yasmin? *

What are other side effects people have besides Depression suicidal? *

Stress And Anxiety: 13 people, 34.21%
Nausea (feeling of having an urge to vomit): 10 people, 26.32%
Suicidal Ideation: 9 people, 23.68%
Mood Swings (an extreme or rapid change in mood): 8 people, 21.05%
Headache (pain in head): 7 people, 18.42%
Disturbance In Attention: 6 people, 15.79%
Fatigue (feeling of tiredness): 6 people, 15.79%
Itching: 6 people, 15.79%
Irritability: 5 people, 13.16%
Crying: 5 people, 13.16%

What are the existing conditions these people have? *

Ill-Defined Disorder: 5 people, 13.16%
Cyclothymic Disorder (mood disorder): 5 people, 13.16%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.26%
Excessive Or Unwanted Hair In Women: 2 people, 5.26%
Asthma: 2 people, 5.26%
Acne (skin problems that cause pimples): 2 people, 5.26%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 2.63%
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 1 person, 2.63%
Endometrial Hyperplasia (enlargement of uterus wall): 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Yasmin and have Depression suicidal?

- Check whether Depression suicidal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Yasmin:

Yasmin (48,855 reports)

Depression suicidal treatments and more:

Depression suicidal (5,503 reports)

How severe was Depression suicidal and when was it recovered:

Depression suicidal in Yasmin

Expand to all the drugs that have ingredients of drospirenone; ethinyl estradiol:

Depression suicidal and drugs with ingredients of drospirenone; ethinyl estradiol

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Depression suicidal:

Depression suicidal (315 drugs)

Browse all the conditions that are associated with Depression suicidal:

Depression suicidal (474 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on drospirenone; ethinyl estradiol (the active ingredients of Yasmin) and Yasmin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.